Comparative_JJ Study_NN of_IN Regulation_NP of_IN RTA-Responsive_NP Genes_NPS in_IN Kaposi_NP 's_POS Sarcoma-Associated_NP Herpesvirus/Human_NP Herpesvirus_NP 8_CD Replication_NN and_CC transcription_NN activator_NN (_( RTA_NP )_) (_( also_RB referred_VBN to_TO as_IN ORF50_NP )_) ,_, an_DT immediate-early_JJ gene_NN product_NN of_IN Kaposi_NP 's_POS sarcoma-associated_JJ herpesvirus_NN (KSHV)/(human_NN herpesvirus_NN 8_CD )_) ,_, plays_VBZ a_DT critical_JJ role_NN in_IN balancing_VBG the_DT viral_JJ life_NN cycle_NN between_IN latency_NN and_CC lytic_JJ replication_NN ._SENT RTA_NP has_VBZ been_VBN shown_VBN to_TO act_VB as_IN a_DT strong_JJ transcription_NN activator_NN for_IN several_JJ downstream_JJ genes_NNS of_IN KSHV_NP ._SENT Direct_JJ binding_NN of_IN RTA_NP to_TO DNA_NP is_VBZ thought_VBN to_TO be_VB one_CD of_IN the_DT important_JJ mechanisms_NNS for_IN transactivation_NN of_IN target_NN genes_NNS ,_, while_IN indirect_JJ mechanisms_NNS are_VBP also_RB implicated_VBN in_IN RTA_NP transactivation_NN of_IN certain_JJ selected_JJ genes_NNS ._SENT This_DT study_NN demonstrated_VBD direct_JJ binding_NN of_IN the_DT DNA-binding_NP domain_NN of_IN RTA_NP (_( Rdbd_NP )_) to_TO a_DT Kaposin_NP (_( Kpsn_NP )_) promoter_NN sequence_NN ,_, which_WDT is_VBZ highly_RB homologous_JJ to_TO the_DT RTA-responsive_JJ element_NN (_( RRE_NN )_) of_IN the_DT PAN_NP promoter_NN ._SENT We_PP undertook_VBD a_DT comparative_JJ study_NN of_IN the_DT RREs_NP of_IN PAN_NP RNA_NP ,_, ORF57_NP ,_, vIL-6_NN ,_, and_CC Kpsn_NP to_TO understand_VB how_WRB RTA_NP regulates_VBZ gene_NN expression_NN during_IN lytic_JJ replication_NN ._SENT Comparing_VBG RNA_NP abundance_NN and_CC transcription_NN initiation_NN rates_NNS of_IN these_DT RTA_NP target_NN genes_NNS in_IN virus-infected_JJ cells_NNS suggested_VBD that_IN the_DT transcription_NN initiation_NN rate_NN of_IN the_DT promoters_NNS is_VBZ a_DT major_JJ determinant_NN of_IN viral_JJ gene_NN expression_NN ,_, rather_RB than_IN stability_NN of_IN the_DT transcripts_NNS ._SENT RTA-mediated_JJ transactivation_NN of_IN reporters_NNS containing_VBG each_DT RRE_NN showed_VBD that_IN their_PP$ promoter_NN strengths_NNS in_IN a_DT transient-transfection_NN system_NN were_VBD comparable_JJ to_TO their_PP$ transcription_NN rates_NNS during_IN reactivation_NN ._SENT Moreover_RB ,_, our_PP$ electrophoretic_JJ mobility_NN shift_NN assays_NNS of_IN each_DT RRE_NN demonstrated_VBD that_IN the_DT highly_RB purified_VBN Rdbd_JJ protein_NN directly_RB bound_VBN to_TO the_DT RREs_NP ._SENT Based_VBN on_IN these_DT results_NNS ,_, we_PP conclude_VBP that_IN direct_JJ binding_NN of_IN RTA_NP to_TO these_DT target_NN sequences_NNS contributes_VBZ to_TO their_PP$ gene_NN expression_NN to_TO various_JJ extents_NNS during_IN the_DT lytic_JJ life_NN cycle_NN of_IN KSHV_NP ._SENT Kaposi_NP 's_POS sarcoma-associated_JJ herpesvirus_NN (_( KSHV_NP )_) ,_, also_RB known_VBN as_IN human_JJ herpesvirus_NN 8_CD (_( HHV-8_NP )_) ,_, is_VBZ an_DT etiological_JJ agent_NN of_IN all_DT clinical_JJ forms_NNS of_IN Kaposi_NP 's_POS sarcoma_NN (_( KS_NP )_) ,_, including_VBG AIDS-associated_NP KS_NP ,_, classic_JJ KS_NP ,_, endemic_JJ forms_NNS of_IN KS_NP ,_, and_CC renal_JJ transplant-related_JJ KS_NP ._SENT KSHV_NP is_VBZ also_RB associated_VBN with_IN two_CD AIDS-related_JJ lymphoproliferative_JJ diseases_NNS ,_, primary_JJ effusion_NN lymphoma_NN (_( PEL_NP )_) and_CC multicentric_JJ Castleman_NP 's_POS disease_NN ._SENT Like_IN other_JJ herpesviruses_NNS ,_, KSHV_NP exhibits_VBZ two_CD distinct_JJ phases_NNS of_IN its_PP$ life_NN cycle_NN ,_, latency_NN and_CC lytic_JJ replication_NN ._SENT Although_IN latent_JJ infection_NN by_IN KSHV_NP has_VBZ been_VBN proposed_VBN to_TO be_VB critical_JJ for_IN tumorigenesis_NN ,_, it_PP is_VBZ clear_JJ that_IN lytic_JJ replication_NN is_VBZ also_RB important_JJ in_IN KSHV_NP pathogenesis_NN ._SENT Most_JJS tumor_NN cells_NNS in_IN KS_NP and_CC PEL_NP are_VBP latently_RB infected_VBN with_IN KSHV_NP ;_: however_RB ,_, the_DT virus_NN undergoes_VBZ lytic_JJ replication_NN in_IN a_DT small_JJ number_NN of_IN cells_NNS in_IN these_DT tumor_NN lesions_NNS ._SENT Upon_IN reactivation_NN of_IN KSHV_NP from_IN latency_NN to_TO lytic_JJ replication_NN ,_, the_DT infected_JJ cells_NNS express_VBP viral_JJ chemokines_NNS and_CC proinflammatory_JJ cytokines_NNS ,_, such_JJ as_IN viral_JJ macrophage_NN inflammatory_JJ proteins_NNS and_CC viral_JJ interleukin-6_NN (_( vIL-6_NN )_) ._SENT These_DT lytic_JJ gene_NN products_NNS may_MD play_VB a_DT key_JJ role_NN in_IN disease_NN progression_NN in_IN an_DT autocrine_NN or_CC paracrine_NN fashion_NN ._SENT In_IN addition_NN ,_, antibodies_NNS against_IN lytic_JJ proteins_NNS are_VBP significantly_RB elevated_VBN in_IN the_DT sera_NN of_IN patients_NNS developing_VBG KS_NP ._SENT Treatment_NN with_IN ganciclovir_NP ,_, a_DT drug_NN that_WDT inhibits_VBZ lytic_JJ replication_NN of_IN herpesviruses_NNS ,_, significantly_RB reduced_VBD the_DT incidence_NN of_IN KS_NP development_NN in_IN AIDS_NP patients_NNS at_IN high_JJ risk_NN for_IN KS_NP ._SENT Therefore_RB ,_, it_PP is_VBZ important_JJ to_TO study_VB the_DT molecular_JJ mechanisms_NNS of_IN reactivation_NN for_IN a_DT better_JJR understanding_NN of_IN KSHV_NP pathogenesis_NN ._SENT KSHV_NP replication_NN and_CC transcription_NN activator_NN (_( RTA_NP )_) (_( also_RB referred_VBN to_TO as_IN ORF50_NP )_) is_VBZ an_DT immediate-early_JJ gene_NN product_NN encoded_VBD primarily_RB by_IN open_JJ reading_NN frame_NN 50_CD (_( ORF50_NP )_) ,_, which_WDT is_VBZ well_RB conserved_VBN among_IN all_DT gammaherpesviruses_NNS ._SENT Ectopic_JJ expression_NN of_IN RTA_NP is_VBZ sufficient_JJ to_TO disrupt_VB latency_NN and_CC activate_VB lytic_JJ replication_NN to_TO completion_NN in_IN latently_RB KSHV-infected_NP PEL_NP cell_NN lines_NNS ._SENT A_DT dominant-negative_JJ mutant_NN of_IN RTA_NP with_IN a_DT 160-amino-acid_JJ deletion_NN at_IN the_DT C_NP terminus_NN inhibited_VBD the_DT ability_NN of_IN RTA_NP to_TO reactivate_VB KSHV_NP from_IN latency_NN ._SENT Thus_RB ,_, the_DT expression_NN of_IN KSHV_NP RTA_NP is_VBZ sufficient_JJ and_CC necessary_JJ for_IN viral_JJ reactivation_NN ,_, indicating_VBG a_DT central_JJ role_NN of_IN RTA_NP in_IN the_DT switch_NN of_IN the_DT viral_JJ life_NN cycle_NN from_IN latency_NN to_TO lytic_JJ replication_NN ._SENT In_IN Epstein-Barr_NP virus_NN (_( EBV_NP )_) (_( a_DT gamma-1_JJ herpesvirus_NN )_) ,_, ZEBRA_NP (_( also_RB referred_VBN to_TO as_IN BZLF1_NP ,_, Zta_NP ,_, or_CC Z_NP )_) plays_VBZ a_DT key_JJ role_NN in_IN disruption_NN of_IN viral_JJ latency_NN in_IN synergy_NN with_IN RTA_NP ._SENT The_DT RTA_NP homologues_NNS from_IN gammaherpesviruses_NNS function_VBP as_IN a_DT transcriptional_JJ activator_NN ,_, and_CC RTA_NP autostimulates_VBZ its_PP$ own_JJ expression_NN ._SENT The_DT Oct-1_NP ,_, Sp1_NP ,_, and_CC Sp3_NP cognate_JJ sites_NNS appear_VBP to_TO be_VB involved_VBN in_IN RTA_NP auto-activation_NN ._SENT KSHV_NP RTA_NP also_RB interacts_VBZ with_IN cellular_JJ factors_NNS ,_, such_JJ as_IN the_DT cyclic_JJ AMP-responsive_JJ element_NN binding_VBG protein-binding_JJ protein_NN (_( CBP_NP )_) ,_, histone_NN deacetylase-1_NN ,_, RBP-Jkappa_NP ,_, and_CC MGC2663_NP (_( named_VBN KSHV_NP RTA_NP binding_JJ protein_NN )_) ._SENT EBV_NP RTA_NP has_VBZ been_VBN shown_VBN to_TO interact_VB with_IN CBP_NP and_CC the_DT retinoblastoma_NN protein_NN ._SENT KSHV_NP RTA_NP transactivates_VBZ the_DT expression_NN of_IN several_JJ downstream_JJ genes_NNS ,_, including_VBG polyadenylated_JJ nuclear_JJ (_( PAN_NP )_) RNA_NP ,_, Kaposin_NP (_( K12_NP )_) ,_, ORF57_NP ,_, K-bZIP_NP (_( K8_NP ,_, the_DT ZEBRA_NP homologue_NN of_IN KSHV_NP )_) ,_, K5_NP ,_, K9_NP ,_, ORF6_NP (_( single-stranded_JJ DNA_NN binding_VBG protein_NN )_) ,_, ORF59_NP (_( DNA_NP polymerase-associated_JJ processivity_NN factor_NN )_) ,_, TK_NP ,_, K14_NP (_( vOX-2_NN )_) ,_, viral_JJ G-protein_NP coupled-receptor_NN ,_, and_CC viral_JJ interleukin-6_NN (_( vIL-6_NN )_) ._SENT EBV_NP RTA_NP alone_RB can_MD activate_VB a_DT subset_NN of_IN lytic_JJ promoters_NNS that_WDT do_VBP not_RB require_VB ZEBRA_NP ,_, and_CC vice_JJ versa_RB ._SENT In_IN other_JJ cases_NNS ,_, RTA_NP activates_VBZ downstream_JJ genes_NNS in_IN synergy_NN with_IN ZEBRA_NP ._SENT However_RB ,_, the_DT molecular_JJ mechanism_NN by_IN which_WDT RTA_NP activates_VBZ target_NN genes_NNS during_IN lytic_JJ replication_NN has_VBZ not_RB yet_RB been_VBN elucidated_VBN ._SENT To_TO date_NN ,_, both_CC direct_JJ and_CC indirect_JJ mechanisms_NNS have_VBP been_VBN suggested_VBN for_IN RTA_NP transactivation_NN ._SENT We_PP previously_RB showed_VBD a_DT very_RB strong_JJ binding_JJ affinity_NN of_IN RTA_NP to_TO the_DT RTA-responsive_JJ element_NN (_( RRE_NN )_) of_IN the_DT PAN_NP promoter_NN (_( pPAN_JJ RRE_NN ;_: 5'-GCTTCCAAAAATGGGTGGCTAACCTGTCCAAAATATGGGAAC-3_NP '_POS )_) ._SENT A_DT sequence_NN search_NN of_IN the_DT KSHV_NP genome_NN revealed_VBD a_DT sequence_NN remarkably_RB similar_JJ to_TO that_DT of_IN pPAN_JJ RRE_NN in_IN the_DT Kaposin_NP promoter_NN ._SENT This_DT sequence_NN of_IN the_DT Kaposin_NP (_( Kpsn_NP )_) promoter_NN (_( 5'-CCCGGGAAATGGGTGGCTAACCCCTACATAAGCAGTTTG-3_NP '_POS )_) contains_VBZ a_DT 25-bp_JJ sequences_NNS (_( shown_VBN in_IN italics_NNS )_) with_IN 16-bp_JJ and_CC additional_JJ 5-bp_JJ matches_NNS with_IN pPAN_NP RRE_NP (_( shown_VBN in_IN bold_JJ type_NN )_) ._SENT Other_JJ research_NN groups_NNS have_VBP shown_VBN that_IN the_DT RTA-responsive_JJ sequence_NN of_IN ORF57_JJ (_( pORF57_JJ RRE_NN ;_: 5'-GCAAGTGTAACAATAATGTTCCCACGGCCC-3_NP '_POS )_) confers_VBZ direct_JJ binding_JJ affinity_NN for_IN RTA_NP ._SENT A_DT highly_RB homologous_JJ sequence_NN of_IN the_DT pORF57_JJ RRE_NN was_VBD also_RB found_VBN in_IN the_DT K-bZIP_NP promoters_NNS (_( 5'-TATTTGTGAAACAATAATGATTAAAGGGG-3_NP '_POS )_) and_CC has_VBZ been_VBN shown_VBN to_TO have_VB a_DT binding_JJ affinity_NN to_TO RTA_NP ._SENT However_RB ,_, a_DT recent_JJ study_NN by_IN Liang_NP et_FW al._FW showed_VBD that_IN a_DT cellular_JJ transcriptional_JJ factor_NN ,_, RBP-Jkappa_NP ,_, plays_VBZ an_DT important_JJ role_NN in_IN recruitment_NN of_IN RTA_NP to_TO the_DT ORF57_JJ promoter_NN ,_, suggesting_VBG a_DT complicated_JJ mode_NN of_IN gene_NN regulation_NN by_IN RTA_NP ._SENT The_DT RREs_NP of_IN the_DT ORF57_JJ and_CC KbZIP_NN promoters_NNS do_VBP not_RB appear_VB to_TO have_VB any_DT significant_JJ sequence_NN homology_NN with_IN those_DT of_IN the_DT PAN_NP and_CC Kpsn_NP promoters_NNS ._SENT Another_DT RRE_NN was_VBD recently_RB identified_VBN which_WDT has_VBZ been_VBN shown_VBN to_TO regulate_VB vIL-6_JJ gene_NN expression_NN (_( pvIL-6RRE_NP ;_: 5'-GTGGTTCTAAGTCGCACGTTAGAAACCCCGCCCCCTGGTGCTCACTTT-3_NP '_POS )_) and_CC to_TO confer_VB binding_JJ affinity_NN for_IN RTA_NP ._SENT Again_RB ,_, there_EX is_VBZ no_DT obvious_JJ homology_NN in_IN the_DT RRE_NN of_IN the_DT vIL-6_JJ promoter_NN to_TO other_JJ known_JJ RREs_NP ._SENT It_PP will_MD be_VB intriguing_JJ to_TO investigate_VB how_WRB RTA_NP can_MD regu-late_VB target_NN gene_NN expression_NN during_IN lytic_JJ replication_NN ,_, utilizing_VBG diverse_JJ sets_NNS of_IN responsive_JJ sequences_NNS ._SENT We_PP undertook_VBD a_DT comparative_JJ study_NN of_IN a_DT group_NN of_IN viral_JJ early_JJ genes_NNS that_WDT are_VBP strongly_RB activated_VBN by_IN RTA_NP ._SENT We_PP measured_VBD steady-state_NN RNA_NP levels_NNS and_CC transcription_NN initiation_NN rates_NNS in_IN virus-infected_JJ cells_NNS ,_, promoter_NN activities_NNS of_IN reporter_NN plasmids_NNS in_IN a_DT transient-transfection_NN system_NN ,_, and_CC in_IN vitro_NP RTA-DNA_NP binding_JJ affinities_NNS ._SENT The_DT results_NNS from_IN these_DT analyses_NNS suggest_VBP that_IN direct_JJ DNA_NN binding_VBG of_IN RTA_NP make_VBP a_DT significant_JJ contribution_NN to_TO the_DT expression_NN of_IN these_DT target_NN genes_NNS during_IN lytic_JJ replication_NN ._SENT Cell_NN culture_NN ._SENT |_SYM All_DT cells_NNS were_VBD cultured_VBN at_IN 37C_JJ in_IN the_DT presence_NN of_IN 5_CD %_NN CO2_NP ._SENT 293T_NP (_( a_DT human_JJ embryonic_JJ kidney_NN cell_NN line_NN transformed_VBN with_IN the_DT E1_JJ region_NN of_IN adenovirus_NN and_CC the_DT simian_JJ virus_NN 40_CD [_SYM SV40_NP ]_SYM T_NN antigen_NN )_) and_CC 293_CD cells_NNS were_VBD cultured_VBN in_IN Dulbecco_NP 's_POS modified_JJ Eagle_NP 's_POS medium_NN (_( Cellgro_NP )_) containing_VBG 10_CD %_NN fetal_JJ bovine_JJ serum_NN (_( FBS_NP )_) and_CC antibiotics_NNS (_( 50_CD U_NN of_IN penicillin/ml_NN and_CC 50_CD mug_NN of_IN streptomycin/ml_NN )_) ._SENT The_DT KS-1_NP cell_NN line_NN was_VBD derived_VBN from_IN primary_JJ effusion_NN lymphoma_NN (_( PEL_NP )_) patient_NN at_IN the_DT University_NP of_IN California_NP at_IN Los_NP Angeles_NP (_( UCLA_NP )_) ,_, which_WDT is_VBZ the_DT same_JJ type_NN of_IN lymphoma_NN as_IN the_DT BC-3_NP cell_NN line_NN ,_, infected_VBN with_IN KSHV_NP ._SENT KS-1_JJ cells_NNS were_VBD maintained_VBN in_IN RPMI_NP 1640_CD medium_NN supplemented_VBN with_IN 10_CD %_NN FBS_NP and_CC antibiotics_NNS ._SENT BJAB_NP or_CC DG75_NP ,_, a_DT human_JJ B-cell_NN line_NN not_RB infected_VBN by_IN any_DT herpesvirus_NN ,_, was_VBD grown_VBN in_IN RPMI_NP 1640_CD containing_VBG 10_CD %_NN FBS_NP and_CC antibiotics_NNS ._SENT Plasmid_NP construction_NN ._SENT |_SYM To_TO make_VB the_DT reporter_NN construct_NN pE4T/Luc_NN ,_, the_DT adenovirus_NN E4_NP minimal_JJ TATA_NP box_NN region_NN was_VBD PCR_NP amplified_VBN from_IN plasmid_NP Z6E4Tluc_NP (_( kindly_RB provided_VBN by_IN M._NP Carey_NP ,_, UCLA_NP )_) ,_, using_VBG a_DT pair_NN of_IN primers_NNS ,_, E4T-F/BglII_NP (_( 5'-tctggaagatctgactctagaggatcc-3_NP '_POS )_) and_CC E4T-R/HindIII_NP (_( 5'-atacccaagcttacaccactcgacacg-3_NP '_POS )_) ,_, and_CC Pfuturbo_NP DNA_NP polymerase_NN (_( Stratagene_NP ,_, La_NP Jolla_NP ,_, Calif._NP )_) ._SENT In_IN all_DT sequences_NNS ,_, the_DT underlined_VBN nucleotides_NNS represent_VBP restriction_NN enzyme_NN sites_NNS ._SENT The_DT PCR_NP product_NN was_VBD cut_VBN with_IN BglII_NP and_CC HindIII_NP and_CC cloned_VBN into_IN the_DT pGL3-basic_JJ plasmid_NP (_( Promega_NP ,_, Madison_NP ,_, Wis._NP )_) which_WDT had_VBD been_VBN cut_VBN with_IN the_DT same_JJ enzymes_NNS ._SENT The_DT luciferase_NN reporter_NN construct_NN pE4T/RREs_NNS contains_VBZ a_DT single_JJ copy_NN of_IN the_DT RREs_NP in_IN the_DT promoters_NNS of_IN PAN_NP RNA_NP ,_, Kaposin_NP (_( Kpsn_NP )_) ,_, ORF57_JJ ,_, and_CC vIL-6_NN in_IN a_DT forward_JJ orientation_NN ._SENT Each_DT RRE_JJ sequence_NN is_VBZ shown_VBN in_IN Fig._NN ._SENT We_PP used_VBD the_DT double-stranded_JJ oligonucleotide_NN pan1_NN (_( 5'-cgggatccGCTTCCAAAAATGGGTGGCTAACCTGTCCAAAATATGGGAACAgatcttcg-3_NP '_POS )_) containing_VBG a_DT region_NN from_IN nucleotide_NN (_( nt_NN )_) -78_CD to_TO -37_CD in_IN the_DT PAN_NP promoter_NN sequence_NN (_( nt_NN 28588_CD to_TO 28629_CD in_IN the_DT KSHV_NP genome_NN )_) to_TO construct_VB pE4T/PAN_NN ._SENT The_DT uppercase_JJ letters_NNS indicate_VBP viral_JJ sequences_NNS ._SENT The_DT double-stranded_JJ oligonucleotide_NN pan1_NN was_VBD cut_VBN with_IN BamHI_NP and_CC BglII_NP and_CC cloned_VBN into_IN pE4T/Luc_NN ,_, which_WDT had_VBD been_VBN cut_VBN with_IN BglII_NP ._SENT The_DT double-stranded_JJ oligonucleotide_NN Kpsn_NP (_( 5'-cgggatccCCCGGGAAATGGGTGGCTAACCCCTACATAAGCAGTTTGagatcttcg-3_NP '_POS ;_: nt_NN 118863_CD to_TO 118825_CD )_) was_VBD used_VBN to_TO generate_VB constructs_NNS for_IN pE4T/Kpsn_NN ,_, K-ORF572_NP (_( 5'-cgggatccGCAAGTGTAACAATAATGTTCCCACGGCCCagatcttcg-3_NP '_POS ;_: nt_NN 81900_CD to_TO 81929_CD )_) for_IN pE4T/ORF57_JJ ,_, and_CC K2p25_NP (_( 5'-cgggatccGTGGTTCTAAGTCGCACGTTAGAAACCCCGCCCCCTGGTGCTCACTTTagatcttcg-3_NP '_POS ;_: nt_NN 18337_CD to_TO 18290_CD )_) for_IN pE4T/vIL-6_NN ._SENT In_IN addition_NN ,_, each_DT RRE_NN was_VBD also_RB cloned_VBN into_IN the_DT pGL3_JJ promoter_NN plasmid_NP (_( Promega_NP )_) containing_VBG the_DT SV40_NP promoter_NN in_IN a_DT similar_JJ manner_NN ,_, resulting_VBG in_IN pSV40/PAN_NN ,_, pSV40/Kpsn_NP ,_, pSV40/ORF57_JJ ,_, and_CC pSV40/vIL-6_NN in_IN a_DT reverse_JJ orient-ation_NN ._SENT The_DT copy_NN numbers_NNS and_CC the_DT orientations_NNS of_IN the_DT inserts_NNS were_VBD confirmed_VBN by_IN sequencing_VBG analysis_NN ._SENT For_IN nuclear_JJ run-on_NN assays_NNS ,_, the_DT sequences_NNS of_IN PAN_NP RNA_NP ,_, Kaposin_NP ,_, and_CC ORF57_JJ were_VBD PCR_NP amplified_VBN from_IN BC-1_NP genomic_JJ DNA_NN ,_, using_VBG a_DT set_NN of_IN primers_NNS specific_JJ for_IN each_DT gene_NN ._SENT pan10/KpnI_NNS and_CC pan2/EcoRI_NNS were_VBD used_VBN for_IN pPAN_NN ,_, containing_VBG the_DT region_NN from_IN nt_NN 28659_CD to_TO 29803_CD of_IN the_DT KSHV_NP genome_NN ,_, KaposinF_NP (_( 5'-ccggaattcACGGAGGACGGATCTCTTGG-3_NP '_POS )_) and_CC KaposinR_NP (_( 5'-cgcggatcctctagaGAACATGTGGCACACGCTGC-3_NP '_POS )_) for_IN pKpsn_NN (_( nt_NN 118741_CD to_TO 117454_CD )_) ,_, and_CC kORF57F_NP (_( 5'-gccgagaattcATGGTACAAGCAATGATAGAC-3_NP '_POS )_) and_CC kORF57R_NP (_( 5'-cgcggatcctctagaGCCATGGGGTTTGGCAATCCTTAAG-3_NP '_POS )_) for_IN pORF57_JJ (_( nt_NN 82069_CD to_TO 83564_CD )_) ._SENT The_DT PCR_NP product_NN for_IN PAN_NP was_VBD cloned_VBN into_IN the_DT pcDNA3_JJ plasmid_NN ._SENT A_DT TA_NP cloning_VBG kit_NN (_( Invitrogen_NP )_) was_VBD used_VBN to_TO clone_NN pKpsn_NNS and_CC pORF57_JJ in_IN the_DT pCRII_NN vector_NN provided_VBN by_IN the_DT manufacturer_NN ._SENT Slot_NN blot_NN analysis_NN of_IN RNA_NP ._SENT |_SYM Total_NP RNA_NP was_VBD extracted_VBN from_IN KS-1_NP cells_NNS uninduced_VBN or_CC induced_VBN with_IN either_DT chemicals_NNS or_CC RTA_NP transfection_NN ,_, using_VBG TriReagent_NP (_( Molecular_NP Research_NP Center_NP ,_, Cincinnati_NP ,_, Ohio_NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ._SENT Five_CD micrograms_NNS of_IN RNA_NP was_VBD denatured_VBN with_IN 7.4_CD %_NN formaldehyde_NN and_CC 6x_NP SSC_NP (_( 1x_NP SSC_NP is_VBZ 0.15_CD M_NP NaCl_NP plus_CC 0.015_CD M_NP sodium_NN citrate_NN )_) for_IN 15_CD min_NN at_IN 65C_JJ and_CC applied_VBN to_TO nylon_NN membranes_NNS using_VBG the_DT slot_NN blot_NN apparatus_NN ._SENT Various_JJ amounts_NNS of_IN DNA_NN containing_VBG the_DT gene_NN of_IN interest_NN without_IN any_DT vector_NN sequences_NNS were_VBD also_RB denatured_VBN in_IN 0.2_CD N_NP NaOH_NP and_CC then_RB neutralized_VBN with_IN an_DT equal_JJ volume_NN of_IN 10_CD M_NP ammonium_NN acetate_NN ._SENT The_DT denatured_VBN DNA_NN mixtures_NNS were_VBD dotted_VBN onto_IN the_DT same_JJ nylon_NN membrane_NN to_TO serve_VB as_IN a_DT standard_NN ._SENT DNA_NN fragments_NNS only_RB containing_VBG a_DT gene_NN of_IN interest_NN were_VBD labeled_VBN ,_, using_VBG a_DT random_JJ priming_NN method_NN ._SENT The_DT membrane_NN was_VBD prehybridized_JJ and_CC then_RB hybridized_VBN with_IN labeled_VBN probes_NNS ,_, as_RB previously_RB described_VBN ._SENT The_DT membranes_NNS were_VBD exposed_VBN to_TO a_DT phosphoimage_NN screen_NN ,_, and_CC quantitative_JJ analysis_NN of_IN signals_NNS was_VBD performed_VBN using_VBG a_DT STORM_NP imaging_NN system_NN (_( Molecular_NP Dynamics_NP ,_, Sunnyvale_NP ,_, Calif._NP )_) ._SENT Nuclear_JJ run-on_NN assays_NNS ._SENT |_SYM Nuclei_NP from_IN 4_CD x_SYM 107_CD KS-1_NP cells_NNS untreated_JJ or_CC treated_VBN with_IN 3_CD mM_NP sodium_NN butyrate_NN for_IN 18_CD h_NN were_VBD isolated_VBN as_IN previously_RB described_VBN ._SENT Briefly_RB ,_, cells_NNS were_VBD washed_VBN twice_RB with_IN cold_JJ 1x_NP phosphate-buffered_JJ saline_NN (_( PBS_NP )_) and_CC resuspended_JJ in_IN 8_CD ml_NN of_IN cold_JJ lysis_NN buffer_NN (_( 10_CD mM_NP Tris-HCl_NP [_SYM pH_NN 7.4_CD ]_SYM ,_, 10_CD mM_NP NaCl_NP ,_, 3_CD mM_NP MgCl2_NP )_) ._SENT The_DT cells_NNS were_VBD then_RB centrifuged_VBN ,_, resuspended_VBN in_IN 4_CD ml_NN of_IN cold_JJ lysis_NN buffer_NN with_IN 0.5_CD %_NN NP-40_NN ,_, and_CC incubated_VBD on_IN ice_NN for_IN 20_CD min_NN ._SENT The_DT lysates_NNS were_VBD passed_VBN 10_CD times_NNS through_IN a_DT 25G5/8_JJ needle_NN and_CC incubated_VBN on_IN ice_NN for_IN another_DT 10_CD min_NN ._SENT The_DT nuclei_NNS pellet_NN was_VBD resuspended_VBN in_IN 210_CD mul_NN of_IN nuclear_JJ storage_NN buffer_NN (_( 50_CD mM_NP Tris-HCl_NP [_SYM pH_NN 8.0_CD ]_SYM ,_, 40_CD %_NN glycerol_NN ,_, 5_CD mM_NP MgCl2_NP ,_, 0.1_CD mM_NP EDTA_NP )_) and_CC stored_VBN at_IN -80C_NN ._SENT Nuclear_JJ run-on_NN assays_NNS were_VBD performed_VBN as_IN previously_RB described_VBN ._SENT Each_DT reaction_NN consisted_VBD of_IN 210_CD mul_NN of_IN nuclei_NNS and_CC 60_CD mul_NN of_IN 5x_NP nuclear_JJ run-on_NN buffer_NN (_( 5x_NN consisting_VBG of_IN 25_CD mM_NP Tris-HCl_NP [_SYM pH_NN 8.0_CD ]_SYM ,_, 12.5_CD mM_NP MgCl2_NP ,_, 750_CD mM_NP KCl_NP ,_, 1.25_CD mM_NP ATP_NP ,_, GTP_NP ,_, and_CC CTP_NP )_) ._SENT [_SYM alpha-32P]-UTP_NN (_( 30_CD mul_NN ;_: 3,000_NP Ci/mM_NP )_) was_VBD then_RB added_VBN ,_, and_CC the_DT nuclear_JJ suspension_NN was_VBD incubated_VBN at_IN 30C_JJ for_IN 30_CD min_NN ,_, after_IN which_WDT DNaseI_NP (_( 345_CD U_NP ;_: GibCO-BRL_NP ,_, Grand_NP Island_NP ,_, N.Y._NP )_) in_IN 10_CD mM_NP CaCl2_NP was_VBD added_VBN ._SENT After_IN 5_CD min_NN at_IN 30C_NP ,_, the_DT reaction_NN was_VBD stopped_VBN with_IN 1x_NP SET_NP (_( 1_CD %_NN sodium_NN dodecyl_JJ sulfate_NN [_SYM SDS_NP ]_SYM ,_, 5_CD mM_NP EDTA_NP ,_, 10_CD mM_NP Tris-HCl_NP [_SYM pH_NN 7.4_CD ]_SYM )_) ,_, and_CC proteinase_NN K_NN was_VBD added_VBN to_TO a_DT concentration_NN of_IN 200_CD mug/ml_NN ._SENT After_IN 45_CD min_NN of_IN incubation_NN at_IN 37C_NP ,_, the_DT solution_NN was_VBD extracted_VBN with_IN an_DT equal_JJ volume_NN of_IN a_DT mixture_NN of_IN phenol_NN and_CC chloroform_NN ,_, and_CC the_DT interphase_NN was_VBD again_RB extracted_VBN with_IN 100_CD mul_NN of_IN 1x_NP SET_NP ._SENT Ammonium_NN acetate_NN (_( 10_CD M_NN )_) was_VBD added_VBN to_TO the_DT combined_JJ aqueous_JJ phases_NNS (_( original_JJ plus_NN reextraction_NN )_) to_TO a_DT final_JJ concentration_NN of_IN 2.3_CD M_NN ,_, an_DT equal_JJ volume_NN of_IN isopropanol_NN was_VBD added_VBN ,_, and_CC nucleic_JJ acid_NN was_VBD precipitated_VBN (_( -70C_NN for_IN 15_CD min_NN )_) ._SENT The_DT precipitate_NN was_VBD centrifuged_VBN ,_, and_CC the_DT pellet_NN was_VBD resuspended_VBN in_IN 100_CD mul_NN of_IN TE_NNS (_( 10_CD mM_NP Tris-HCl_NP [_SYM pH_NN 8.0_CD ]_SYM ,_, 1_CD mM_NP EDTA_NP )_) ._SENT Unincorporated_JJ nucleotides_NNS were_VBD removed_VBN using_VBG a_DT G-25_NP spin_NN column_NN ._SENT NaOH_NP was_VBD added_VBN to_TO the_DT elute_VBP at_IN a_DT final_JJ concentration_NN 0.2_CD N_NN and_CC incubated_VBN for_IN 10_CD min_NN on_IN ice_NN ._SENT HEPES_NNS was_VBD added_VBN to_TO a_DT concentration_NN of_IN 0.24_CD M_NN ,_, and_CC then_RB 2.5_CD vol_NN of_IN ethanol_NN was_VBD added_VBN to_TO precipitate_VB labeled_VBN RNA_NP overnight_JJ at_IN -20C_NN ._SENT The_DT pellet_NN was_VBD resuspended_VBN in_IN hybridization_NN buffer_NN (_( 10_CD mM_NP TES_NP [_SYM pH_NN 7.4_CD ]_SYM ,_, 0.2_CD %_NN SDS_NP ,_, 10_CD mM_NP EDTA_NP ,_, 0.3_CD M_NP NaCl_NP ,_, 1x_NP Denhardt_NP 's_POS solution_NN ,_, yeast_NN tRNA_NN [_SYM 250_CD mug/ml_NN ]_SYM )_) ._SENT Nylon_NN membranes_NNS containing_VBG denatured_VBN plasmid_NP DNAs_NP were_VBD prepared_VBN using_VBG a_DT slot_NN blot_NN apparatus_NN (_( GibCO-BRL_NP )_) ._SENT Plasmids_NNS used_VBN for_IN the_DT templates_NNS were_VBD pPAN_JJ (_( a_DT 1.1-kb_JJ fragment_NN of_IN the_DT PAN_NP RNA_NP sequence_NN in_IN pcDNA3_NN )_) ,_, pKpsn_NN (_( a_DT 1.3-kb_JJ fragment_NN of_IN the_DT Kpsn_NP ORF_NP and_CC GC-rich_NP upstream_JJ direct_JJ repeats_NNS in_IN pCRII_NNS )_) ,_, pORF57_JJ (_( a_DT 1.5-kb_JJ fragment_NN of_IN the_DT ORF57_JJ coding_VBG sequence_NN in_IN pCRII_NP )_) ,_, pvIL-6_NN (_( a_DT 0.6-kb_NN fragment_NN of_IN vIL-6_NP ORF_NP in_IN pcDNA3.1_NN )_) ,_, and_CC pGAPDH_NP (_( glyceraldehyde-3-phosphate_NN dehydrogenase_NN [_SYM GAPDH_NP ]_SYM ;_: a_DT 0.6-kb_NN fragment_NN of_IN the_DT 3'-end_JJ of_IN GAPDH_NP in_IN pCRII_NP )_) ._SENT After_IN overnight_JJ prehybridization_NN ,_, the_DT membranes_NNS were_VBD hybridized_VBN with_IN the_DT nuclear_JJ run-on_NN products_NNS (_( 107_CD cpm_NN )_) for_IN 36_CD h_NN at_IN 65C_JJ ._SENT The_DT radioactivity_NN of_IN labeled_VBN products_NNS was_VBD measured_VBN using_VBG a_DT scintillation_NN counter_NN ,_, LS1800_NP (_( Beckman_NP Coulter_NP ,_, Fullerton_NP ,_, Calif._NP )_) ._SENT After_IN hybridization_NN ,_, the_DT membranes_NNS were_VBD washed_VBN twice_RB with_IN 0.1_CD %_NN SDS_NP and_CC 2x_NP SSC_NP for_IN 30_CD min_NN and_CC then_RB washed_VBN twice_RB with_IN 0.1_CD %_NN SDS_NP and_CC 0.1x_NP SSC_NP for_IN 30_CD min_NN at_IN 65C_JJ ._SENT The_DT membranes_NNS were_VBD exposed_VBN to_TO a_DT phosphoimage_NN screen_NN ,_, and_CC quantitative_JJ analysis_NN of_IN signals_NNS was_VBD performed_VBN using_VBG a_DT STORM_NP imaging_NN system_NN (_( Molecular_NP Dynamics_NPS )_) ._SENT Transfections_NNS ._SENT |_SYM For_IN the_DT luciferase_JJ reporter_NN assays_NNS ,_, 2.5_CD x_SYM 105_CD 293T_JJ cells_NNS were_VBD transfected_VBN with_IN 100_CD ng_NNS of_IN pcDNA3_NP or_CC pcDNA3/RTA_NP and_CC 20_CD ng_NNS of_IN a_DT reporter_NN plasmid_NN into_IN 12-well_NP plates_NNS ,_, using_VBG a_DT calcium-phosphate_NN transfection_NN method_NN ._SENT Each_DT transfection_NN for_IN reporter_NN assays_NNS was_VBD performed_VBN in_IN duplicate_NN and_CC contained_VBD 10_CD ng_NNS of_IN pRLSV40_NN (_( Promega_NP )_) as_IN a_DT control_NN for_IN transfection_NN efficiencies_NNS ,_, as_RB well_RB as_IN 270_CD ng_NNS of_IN pcDNA3_NN ._SENT At_IN 24_CD h_NN posttransfection_NN ,_, cells_NNS were_VBD washed_VBN with_IN 1x_NP PBS_NP and_CC subjected_VBN to_TO reporter_NN assays_NNS ._SENT BJAB_NP or_CC KS-1_NP cells_NNS (_( 5_CD x_SYM 105_CD )_) were_VBD transfected_VBN with_IN 250_CD ng_NNS of_IN pcDNA3_NP or_CC pcDNA3/RTA_NP and_CC 50_CD ng_NNS of_IN a_DT reporter_NN plasmid_NN into_IN 24-well_JJ plates_NNS ,_, using_VBG the_DT Lipofectamine_NP 2000_CD reagent_NN (_( Invitrogen_NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ._SENT In_IN addition_NN ,_, each_DT transfection_NN contained_VBD 10_CD ng_NNS of_IN pRLSV40_NN and_CC 700_CD ng_NNS of_IN pcDNA3_NN ._SENT At_IN 24_CD h_NN posttransfection_NN ,_, cells_NNS were_VBD harvested_VBN ,_, washed_VBN with_IN 1x_NP PBS_NP ,_, and_CC subjected_VBN to_TO reporter_NN assays_NNS ._SENT Dual_JJ luciferase_NN assays_NNS ._SENT |_SYM The_DT dual_JJ luciferase_NN reporter_NN assay_NN system_NN (_( Promega_NP )_) was_VBD used_VBN to_TO test_VB promoter_NN activity_NN ._SENT Transfected_JJ 293T_JJ cells_NNS in_IN 12-well_NP plates_NNS were_VBD washed_VBN with_IN 1x_NP PBS_NP and_CC incubated_VBN with_IN 250_CD mul_NN of_IN 1x_NP passive_JJ lysis_NN buffer_NN provided_VBN by_IN the_DT manufacturer_NN ._SENT Transfected_NP BJAB_NP or_CC KS-1_NP cells_NNS were_VBD resuspended_VBN in_IN 100_CD mul_NN of_IN 1x_NP passive_JJ lysis_NN buffer_NN after_IN being_VBG washed_VBN with_IN 1x_NP PBS_NP ._SENT Lysates_NNS were_VBD frozen_VBN ,_, thawed_VBN once_RB ,_, and_CC centrifuged_VBN at_IN top_JJ speed_NN in_IN a_DT microcentrifuge_NN for_IN 5_CD min_NN ._SENT Lysates_NNS were_VBD assayed_VBN using_VBG a_DT Luminometer_NP Lmax_NP (_( Molecular_NP Devices_NP ,_, Sunnyvale_NP ,_, Calif._NP )_) ._SENT The_DT reporter_NN assays_NNS were_VBD carried_VBN out_IN according_VBG to_TO the_DT manufacturer_NN 's_POS protocol_NN for_IN the_DT dual_JJ luciferase_NN reporter_NN assay_NN system_NN (_( Promega_NP )_) ._SENT The_DT Renilla_NP luciferase_NN activities_NNS from_IN the_DT pRLSV40_JJ plasmid_NN were_VBD not_RB affected_VBN in_IN cotransfection_NN of_IN RTA_NP in_IN the_DT cell_NN lines_NNS tested_VBD ,_, including_VBG 293_CD ,_, 293T_NP ,_, BJAB_NP ,_, and_CC KS-1_NP cells_NNS ,_, and_CC were_VBD therefore_RB ,_, used_VBN as_IN an_DT internal_JJ control_NN to_TO normalize_VB transfection_NN efficiency_NN in_IN different_JJ transfection_NN samples_NNS ._SENT EMSAs_NP ._SENT |_SYM The_DT recombinant_JJ Rdbd_NN protein_NN (_( amino_NN acids_NNS 1_CD to_TO 320_CD )_) tagged_VBN with_IN a_DT FLAG_NP peptide_NN at_IN the_DT N_NP terminus_NN and_CC six_CD histidine_NN residues_NNS at_IN the_DT C_NP terminus_NN was_VBD expressed_VBN in_IN bacteria_NNS and_CC purified_VBD as_RB previously_RB described_VBN ._SENT A_DT set_NN of_IN double-stranded_JJ oligonucleotides_NNS ,_, including_VBG pan1_JJ (_( pPAN_NP RRE_NP )_) ,_, MJmulti_NP (_( a_DT mutant_JJ version_NN of_IN pPAN_NP RRE_NP )_) ,_, Kpsn_NP (_( pKpsn_NP RRE_NP )_) ,_, Kpsn/TG_NP (_( a_DT mutant_JJ version_NN of_IN pKpsn_NP RRE_NP )_) ,_, K-ORF572_NP (_( pORF57_JJ RRE_NN )_) ,_, and_CC K2p25_NP (_( pvIL-6_NP RRE_NP )_) were_VBD used_VBN for_IN electrophoretic_JJ mobility_NN shift_NN assays_NNS (_( EMSAs_NP )_) ,_, (_( see_VB Fig._NN and_CC for_IN sequences_NNS )_) ._SENT Two_CD pairs_NNS of_IN unrelated_JJ sequences_NNS ,_, NS1_NP (_( 5'-cgagatcggggtgaggcatgggggatcccg-3_NP '_POS )_) and_CC NS2_NP (_( 5'-cgggatccgagatcgaagtgaggcatgggggatgagatcttcg-3_NP '_POS )_) ,_, were_VBD synthesized_VBN and_CC serve_VB as_IN negative_JJ controls_NNS for_IN EMSA_NP ._SENT All_DT double-stranded_JJ oligonucleotides_NNS were_VBD end_NN labeled_VBN with_IN [_SYM gamma-32P]ATP_NN followed_VBN by_IN fill-in_NN reaction_NN ,_, and_CC EMSAs_NP were_VBD performed_VBN as_IN previously_RB described_VBN ._SENT For_IN competition_NN assays_NNS ,_, various_JJ amounts_NNS of_IN cold_JJ competitors_NNS (_( indicated_VBN in_IN Fig._NN )_) were_VBD incubated_VBN with_IN the_DT purified_VBN Rdbd_NN protein_NN 30_CD min_NN prior_JJ to_TO the_DT addition_NN of_IN end-labeled_JJ probes_NNS ._SENT Supershift_NN assays_NNS were_VBD performed_VBN using_VBG a_DT monoclonal_NN antibody_NN (_( 2.2_CD mug_NN )_) against_IN a_DT FLAG_NP peptide_NN (_( Sigma_NP )_) and_CC polyclonal_JJ rabbit_NN sera_NN against_IN RTA_NP (_( 1_CD mul_NN )_) ._SENT Normal_JJ rabbit_NN sera_NN (_( 1_CD mul_NN )_) as_RB well_RB as_IN polyclonal_JJ rabbit_NN sera_NN against_IN an_DT irrelevant_JJ protein_NN (_( 1_CD mul_NN )_) were_VBD also_RB used_VBN as_IN a_DT negative_JJ control_NN for_IN supershift_NN assays_NNS ._SENT Comparison_NN of_IN RTA_NP binding_VBG affinities_NNS for_IN PAN_NP and_CC Kaposin_NP promoters_NNS ._SENT RTA_NP has_VBZ been_VBN shown_VBN to_TO act_VB as_IN a_DT strong_JJ transcription_NN activator_NN for_IN several_JJ downstream_JJ genes_NNS of_IN KSHV_NP ,_, including_VBG PAN_NP RNA_NP ,_, ORF57_NP ,_, K-bZIP_NP ,_, Kaposin_NP ,_, vIL-6_NP ,_, K14_NP ,_, viral_JJ G-protein_NP coupled-receptor_NN ,_, and_CC thymidine_NN kinase_NN ._SENT We_PP previously_RB used_VBD a_DT highly_RB purified_VBN RTA_NP binding_JJ domain_NN protein_NN (_( Rdbd_NP )_) to_TO demonstrate_VB a_DT very_RB strong_JJ binding_JJ affinity_NN of_IN RTA_NP for_IN the_DT RRE_NN in_IN the_DT PAN_NP promoter_NN (_( pPAN_JJ RRE_NN ;_: 5'-GCTTCCAAAAATGGGTGGCTAACCTGTCCAAAATATGGGAAC-3_NP '_POS )_) ._SENT Through_IN sequence_NN analysis_NN of_IN the_DT KSHV_NP genome_NN ,_, it_PP was_VBD noted_VBN that_IN the_DT Kaposin_NP promoter_NN bears_VBZ remarkable_JJ homology_NN with_IN the_DT pPAN_JJ RRE_NN sequence_NN ._SENT The_DT sequence_NN of_IN the_DT Kaposin_NP (_( Kpsn_NP )_) promoter_NN (_( 5'-CCCGGGAAATGGGTGGCTAACCCCTACATAAGCAGTTTG-3_NP '_POS )_) contains_VBZ a_DT 25-bp_JJ homologous_JJ sequence_NN of_IN pPAN_NP RRE_NP (_( shown_VBN in_IN italics_NNS )_) with_IN a_DT 16-bp_JJ consecutive_JJ sequence_NN and_CC 5-bp_JJ additional_JJ exact_JJ matches_NNS (_( shown_VBN in_IN bold_JJ type_NN )_) ._SENT We_PP tested_VBD whether_IN this_DT sequence_NN in_IN the_DT Kaposin_NP promoter_NN confers_VBZ RTA_NP binding_JJ affinity_NN ._SENT End-labeled_JJ probes_NNS ,_, PAN*_NP and_CC Kpsn*_NP (_( asterisks_NNS indicate_VBP labeled_VBN oligonucleotides_NNS )_) ,_, were_VBD incubated_VBN with_IN 20_CD or_CC 50_CD ng_NNS of_IN Rdbd_NN and_CC yielded_VBD a_DT specific_JJ complex_NN with_IN Rdbd_NP ,_, suggesting_VBG that_IN RTA_NP binds_VBZ to_TO the_DT Kaposin_NP promoter_NN (_( Fig._NN ,_, lane_NN 5_CD )_) ._SENT Rdbd_JJ binding_JJ affinity_NN for_IN Kpsn*_NP was_VBD fourfold_RB lower_JJR than_IN that_DT for_IN PAN*_NP ._SENT Throughout_IN the_DT paper_NN ,_, we_PP calculated_VBD percent_NN binding_VBG of_IN an_DT RRE_NN as_IN a_DT ratio_NN of_IN the_DT bound_JJ probe_NN to_TO the_DT total_JJ (_( bound_VBN plus_CC unbound_VBN )_) probe_NN using_VBG a_DT software_NN program_NN (_( ImageQuant_NP version_NN 1.1_CD )_) to_TO quantitate_VB signals_NNS from_IN EMSA_NP gels_NNS ._SENT Our_PP$ previous_JJ detailed_JJ analysis_NN of_IN pPAN_NP RRE_NP showed_VBD that_IN mutations_NNS at_IN the_DT 3_CD '_POS end_NN (_( nt_NN -46_CD to_TO -54_CD )_) of_IN the_DT shared_VBN sequence_NN with_IN Kpsn_NP significantly_RB reduced_VBD Rdbd_JJ binding_JJ affinities_NNS in_IN vitro_NN compared_VBN to_TO the_DT wild_JJ type_NN (_( wt_NN )_) ._SENT To_TO test_VB whether_IN Kpsn*_NP mimicked_VBD the_DT pPAN_JJ RRE_NN mutants_NNS ,_, which_WDT have_VBP different_JJ nucleotides_NNS at_IN the_DT positions_NNS critical_JJ for_IN Rdbd_JJ binding_NN ,_, we_PP introduced_VBD a_DT 2-bp_JJ mutation_NN into_IN Kpsn_NP (_( CC->TG_NP )_) ._SENT Now_RB ,_, Kpsn/TG_NP shares_NNS 27_CD bp_NN matches_NNS ,_, including_VBG the_DT 19-bp_JJ consecutive_JJ sequence_NN and_CC 5_CD mismatches_NNS at_IN nt_NN -52_CD ,_, -49_CD ,_, and_CC -46_CD to_TO -44_CD ,_, of_IN pPAN_NN RRE_NN ._SENT Once_IN percent_NN binding_VBG of_IN each_DT probe_NN ,_, PAN*_NP ,_, Kpsn*_NP ,_, or_CC Kpsn/TG*_NP ,_, was_VBD calculated_VBN ,_, we_PP set_VBD PAN_NP binding_VBG as_IN 100_CD %_NN to_TO show_VB Kpsn*_NP and_CC Kpsn/TG*_NP binding_VBG of_IN RTA_NP in_IN a_DT scale_NN relative_JJ to_TO that_DT for_IN PAN*_NP ._SENT EMSA_NP results_NNS with_IN 32P-labeled_JJ Kpsn/TG*_NP showed_VBD that_IN an_DT Rdbd_JJ binding_JJ affinity_NN for_IN Kpsn/TG*_NP is_VBZ higher_JJR than_IN that_DT for_IN Kpsn*_NP but_CC still_RB lower_JJR than_IN that_DT for_IN PAN*_NP (_( Fig._NN ,_, lanes_NNS 4_CD to_TO 6_CD ,_, and_CC 1C_NP )_) ._SENT This_DT difference_NN between_IN Kpsn*_NP and_CC Kpsn/TG*_NP is_VBZ statistically_RB significant_JJ (_( P_NN <_0.05, A_NP )_) showed_VBD 60_CD %_NN relative_JJ binding_NN of_IN wt_JJ pPAN_NN RRE_NN ._SENT Two-base_JJ pair_NN mutations_NNS at_IN nt_JJ -49_CD and_CC -48_CD (_( MJ49_NP :_: AA->CC_NP )_) or_CC at_IN nt_JJ -47_CD and_CC -46_CD (_( MJ47_NP :_: AT->CG_NP )_) showed_VBD 40_CD to_TO 50_CD %_NN of_IN wt_NN binding_NN ._SENT Hence_RB ,_, Kpsn/TG_NP behaves_VBZ similarly_RB to_TO these_DT pPAN_JJ RRE_NN mutants_NNS in_IN terms_NNS of_IN reduced_VBN Rdbd_NN binding_NN ,_, suggesting_VBG that_IN the_DT Kpsn_NP sequence_NN may_MD be_VB a_DT derivative_NN of_IN a_DT very_RB strong_JJ RRE_NN of_IN the_DT PAN_NP promoter_NN ._SENT Transcript_NN abundance_NN and_CC transcription_NN initiation_NN rates_NNS of_IN RTA-responsive_JJ viral_JJ genes_NNS during_IN lytic_JJ replication_NN ._SENT |_SYM Others_NNS have_VBP reported_VBN that_IN RTA_NP expressed_VBD using_VBG a_DT baculovirus_NN expression_NN system_NN binds_VBZ to_TO the_DT RREs_NP in_IN the_DT ORF57_JJ promoter_NN (_( pORF57_JJ RRE_NN )_) ._SENT In_IN addition_NN ,_, a_DT highly_RB homologous_JJ sequence_NN of_IN pORF57_JJ RRE_NN was_VBD noted_VBN in_IN the_DT KbZIP_NP promoter_NN and_CC was_VBD shown_VBN to_TO confer_VB RTA_NP binding_JJ activity_NN ._SENT There_EX is_VBZ no_DT apparent_JJ homology_NN between_IN pORF57_JJ RRE_NN and_CC pPAN_NN RRE_NN ._SENT The_DT RRE_NN from_IN the_DT vIL-6_JJ promoter_NN (_( pvIL-6_NP RRE_NP )_) was_VBD identified_VBN and_CC shown_VBN to_TO bind_VB to_TO bacterially_RB expressed_VBN RTA_NP protein_NN ._SENT This_DT sequence_NN is_VBZ unique_JJ among_IN other_JJ known_JJ RREs_NP ,_, without_IN any_DT apparent_JJ homology_NN ._SENT Thus_RB ,_, we_PP undertook_VBD a_DT comparative_JJ study_NN of_IN these_DT RTA_NP target_NN genes_NNS to_TO understand_VB how_WRB RTA_NP activates_VBZ diverse_JJ sets_NNS of_IN responsive_JJ elements_NNS ._SENT First_RB ,_, we_PP sought_VBD to_TO determine_VB relative_JJ expression_NN levels_NNS of_IN these_DT genes_NNS in_IN virus-infected_JJ cells_NNS ._SENT We_PP assessed_VBD the_DT abundance_NN of_IN RTA-responsive_JJ gene_NN transcripts_NNS in_IN KS-1_NP cells_NNS during_IN lytic_JJ replication_NN ,_, using_VBG slot_NN blot_NN analysis_NN ._SENT Total_NP RNAs_NP were_VBD extracted_VBN from_IN KS-1_NP and_CC DG75_NP (_( a_DT human_JJ B-cell_NN line_NN without_IN viral_JJ infection_NN )_) cells_NNS untreated_JJ or_CC treated_VBN for_IN 18_CD h_NN with_IN 3_CD mM_NP sodium_NN butyrate_NN ,_, a_DT known_VBN strong_JJ activator_NN of_IN KSHV_NP lytic_JJ replication_NN ._SENT Total_NP RNA_NP (_( 5_CD mug_NN )_) immobilized_VBN on_IN a_DT membrane_NN was_VBD hybridized_VBN with_IN the_DT probe_NN specific_JJ to_TO each_DT sequence_NN of_IN the_DT RTA-responsive_JJ genes_NNS tested_VBD ._SENT The_DT membrane_NN also_RB included_VBD DNA_NN of_IN known_VBN amounts_NNS for_IN each_DT gene_NN to_TO serve_VB as_IN a_DT standard_NN ._SENT Gene_NN expression_NN levels_NNS in_IN KS-1_NP cells_NNS from_IN the_DT hybridized_VBN membranes_NNS were_VBD calculated_VBN and_CC compared_VBN to_TO the_DT signals_NNS obtained_VBN from_IN the_DT standards_NNS ._SENT No_DT cross-hybridization_NN to_TO RNA_NP was_VBD detected_VBN from_IN DG-75_NP cells_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT There_EX were_VBD relatively_RB high_JJ levels_NNS of_IN Kpsn_NP and_CC vIL-6_JJ transcripts_NNS in_IN uninduced_JJ cells_NNS ._SENT The_DT amount_NN of_IN PAN_NP RNA_NP was_VBD estimated_VBN to_TO be_VB 3.9_CD ng_NNS out_RB of_IN 5_CD mug_NN of_IN total_JJ RNA_NP from_IN induced_VBN KS-1_NP cells_NNS ._SENT Assuming_VBG the_DT portion_NN of_IN poly(A)_NP RNA_NP in_IN total_JJ RNA_NP in_IN eukaryotic_JJ cells_NNS is_VBZ 1_CD to_TO 4_CD %_NN and_CC the_DT percentage_NN of_IN PEL_NP cells_NNS undergoing_VBG lytic_JJ replication_NN upon_IN chemical_NN induction_NN is_VBZ 10_CD to_TO 20_CD %_NN ,_, PAN_NP RNA_NP was_VBD calculated_VBN to_TO constitute_VB 10_CD to_TO 80_CD %_NN of_IN total_JJ polyadenylated_JJ RNA_NP ,_, consistent_JJ with_IN our_PP$ previous_JJ observation_NN ._SENT Although_IN expressions_NNS of_IN other_JJ genes_NNS were_VBD somewhat_RB comparable_JJ in_IN induced_VBN KS-1_NP cells_NNS ,_, besides_IN PAN_NP RNA_NP being_VBG by_IN far_RB the_DT most_RBS abundant_JJ ,_, relative_JJ expression_NN levels_NNS were_VBD in_IN order_NN of_IN Kpsn_NP ,_, ORF57_JJ ,_, and_CC vIL-6_NN ._SENT The_DT expression_NN level_NN of_IN a_DT gene_NN is_VBZ determined_VBN by_IN two_CD factors_NNS ,_, frequency_NN of_IN transcription_NN initiation_NN and_CC RNA_NP stability_NN ._SENT Therefore_RB ,_, we_PP further_RBR examined_VBD the_DT transcription_NN rates_NNS of_IN the_DT RTA-responsive_JJ viral_JJ genes_NNS ,_, PAN_NP RNA_NP ,_, Kpsn_NP ,_, ORF57_JJ ,_, and_CC vIL-6_NN ,_, using_VBG nuclear_JJ run-on_NN assays_NNS ._SENT Nuclear_JJ run-on_NN assays_NNS provide_VBP a_DT measure_NN of_IN the_DT frequency_NN of_IN transcription_NN initiation_NN that_WDT contributes_VBZ to_TO regulated_VBN gene_NN expression_NN and_CC is_VBZ largely_RB independent_JJ of_IN RNA_NP stability_NN ._SENT The_DT numbers_NNS of_IN nascent_JJ transcripts_NNS on_IN the_DT gene_NN are_VBP thought_VBN to_TO be_VB proportional_JJ to_TO the_DT numbers_NNS of_IN paused_VBN RNA_NP polymerase_NN complexes_NNS on_IN the_DT DNA_NP template_NN ,_, indicating_VBG the_DT frequency_NN of_IN transcription_NN initiation_NN ._SENT Nuclei_NNS from_IN KS-1_NP cells_NNS untreated_JJ or_CC treated_VBN with_IN 3_CD mM_NP sodium_NN butyrate_NN for_IN 18_CD h_NN were_VBD isolated_VBN and_CC incubated_VBN with_IN ATP_NP ,_, CTP_NP ,_, GTP_NP ,_, and_CC radiolabeled_JJ UTP_NN ._SENT The_DT majority_NN of_IN radiolabeled_JJ nascent_JJ transcripts_NNS from_IN uninduced_JJ and_CC induced_VBN KS-1_NP cells_NNS ran_VBD equivalent_JJ to_TO the_DT size_NN of_IN 200_CD to_TO 300_CD nt_NNS ,_, suggesting_VBG that_IN the_DT nuclear_JJ run-on_NN reactions_NNS were_VBD efficient_JJ (_( data_NNS not_RB shown_VBN )_) ._SENT Radiolabeled_NP newly_RB synthesized_VBD RNAs_NP from_IN uninduced_JJ and_CC induced_VBN KS-1_NP nuclei_NNS were_VBD hybridized_VBN with_IN a_DT membrane_NN containing_VBG immobilized_VBN DNA_NN templates_NNS of_IN RTA-responsive_JJ viral_JJ genes_NNS ,_, as_RB well_RB as_IN GAPDH_NP as_IN a_DT control_NN ._SENT DNA_NP templates_NNS included_VBD genomic_JJ sequences_NNS encompassing_VBG the_DT ORF_NP of_IN each_DT gene_NN in_IN a_DT vector_NN ,_, as_RB described_VBN in_IN Materials_NPS and_CC Methods_NP ,_, except_IN PAN_NP RNA_NP and_CC Kpsn_NP ._SENT A_DT template_NN for_IN PAN_NP contains_VBZ 1.1_CD kb_NN of_IN the_DT PAN_NP RNA_NP genomic_JJ sequence_NN ,_, and_CC that_IN for_IN Kpsn_NP contains_VBZ upstream_JJ sequences_NNS of_IN GC_NP direct_JJ repeats_NNS in_IN addition_NN to_TO the_DT Kpsn_NP ORF_NP (_( K12_NP )_) ._SENT Results_NNS from_IN the_DT nuclear_JJ run-on_NN assays_NNS are_VBP shown_VBN in_IN Fig._NN ._SENT For_IN quantitative_JJ analysis_NN of_IN data_NNS ,_, the_DT signal_NN for_IN GAPDH_NP in_IN uninduced_JJ KS-1_NP cells_NNS was_VBD set_VBN as_IN 1_CD ,_, and_CC those_DT for_IN other_JJ genes_NNS were_VBD quantitated_VBN relative_JJ to_TO the_DT value_NN of_IN GAPDH_NP ._SENT Compared_VBN with_IN those_DT from_IN uninduced_JJ KS-1_NP cells_NNS ,_, high_JJ levels_NNS of_IN radiolabeled_JJ nascent_JJ transcripts_NNS of_IN these_DT genes_NNS were_VBD detected_VBN in_IN induced_VBN KS-1_NP cells_NNS ,_, which_WDT reflects_VBZ the_DT dramatic_JJ increase_NN in_IN transcription_NN rates_NNS of_IN these_DT genes_NNS upon_IN induction_NN of_IN lytic_JJ replication_NN ._SENT Similar_JJ to_TO results_NNS obtained_VBN from_IN slot_NN blot_NN analysis_NN ,_, it_PP was_VBD noted_VBN that_IN there_EX was_VBD limited_JJ but_CC detectable_JJ radiolabeled_JJ viral_JJ lytic_JJ transcription_NN from_IN uninduced_JJ KS-1_NP cells_NNS (_( Fig._NN ,_, left_VBN panel_NN )_) ._SENT In_IN induced_VBN KS-1_NP cells_NNS ,_, the_DT transcription_NN initiation_NN rates_NNS of_IN tested_VBN viral_JJ genes_NNS were_VBD consistent_JJ with_IN their_PP$ RNA_NP abundance_NN ,_, suggesting_VBG that_DT expression_NN of_IN these_DT RTA_NP target_NN genes_NNS is_VBZ mainly_RB regulated_VBN at_IN the_DT transcriptional_JJ level_NN ,_, rather_RB than_IN at_IN the_DT posttranscription_NN levels_NNS (_( Fig._NN ,_, right_JJ panel_NN )_) ._SENT For_IN direct_JJ comparison_NN of_IN the_DT effect_NN of_IN RTA_NP on_IN endogenous_JJ RTA-responsive_JJ gene_NN expression_NN ,_, we_PP also_RB performed_VBD transfection_NN of_IN RTA_NP in_IN KSHV-infected_NP cells_NNS and_CC obtained_VBN similar_JJ results_NNS ._SENT Either_DT pcDNA3_JJ vector_NN alone_RB or_CC pcDNA3/RTA_NP was_VBD transfected_VBN into_IN KS-1_NP cells_NNS ._SENT Total_NP RNA_NP was_VBD harvested_VBN at_IN 40_CD h_NN posttransfection_NN and_CC subjected_VBN to_TO the_DT slot_NN blot_NN analysis_NN ._SENT Upon_IN RTA_NP expression_NN ,_, viral_JJ transcripts_NNS in_IN RTA-transfected_JJ cells_NNS were_VBD strongly_RB induced_VBN and_CC correlated_VBN with_IN their_PP$ transcription_NN initiation_NN rates_NNS ._SENT We_PP also_RB obtained_VBD similar_JJ results_NNS when_WRB we_PP used_VBD a_DT different_JJ KSHV-infected_NP cell_NN line_NN ,_, BCBL-1_JJ (_( data_NNS not_RB shown_VBN )_) ._SENT Slot_NN blot_NN analysis_NN of_IN RNAs_NP from_IN KS-1_NP and_CC BCBL-1_NP cells_NNS treated_VBN with_IN 3_CD mM_NP sodium_NN butyrate_NN for_IN 40_CD h_NN also_RB showed_VBD comparable_JJ trends_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT All_RB together_RB ,_, these_DT data_NNS suggest_VBP that_IN RTA_NP regulates_VBZ its_PP$ target_NN gene_NN expression_NN primarily_RB at_IN the_DT level_NN of_IN transcription_NN of_IN the_DT promoters_NNS ._SENT The_DT transcription_NN activities_NNS of_IN the_DT RRE_JJ promoters_NNS mediated_VBN by_IN RTA_NP in_IN reporter_NN assays_NNS ._SENT |_SYM The_DT RREs_NP have_VBP been_VBN identified_VBN for_IN all_DT four_CD promoters_NNS and_CC shown_VBN to_TO be_VB critical_JJ for_IN promoter_NN activation_NN by_IN RTA_NP ._SENT We_PP investigated_VBD whether_IN promoter_NN strengths_NNS of_IN RTA-responsive_JJ genes_NNS would_MD be_VB a_DT key_JJ factor_NN for_IN their_PP$ gene_NN expression_NN ._SENT Since_IN the_DT distances_NNS between_IN a_DT TATA_NP box_NN and_CC an_DT RRE_NN and_CC putative_JJ binding_JJ sites_NNS for_IN cellular_JJ proteins_NNS varied_VBN in_IN their_PP$ own_JJ promoter_NN contexts_NNS ,_, we_PP tested_VBD the_DT strength_NN of_IN the_DT RREs_NP in_IN a_DT uniform_JJ background_NN ._SENT All_PDT the_DT RRE_JJ sequences_NNS are_VBP listed_VBN in_IN Fig._NN ,_, with_IN numbers_NNS indicating_VBG genomic_JJ locations_NNS ._SENT These_DT RREs_NP were_VBD fused_VBN to_TO a_DT heterologous_JJ promoter_NN ,_, using_VBG a_DT luciferase_NN reporter_NN construct_NN ,_, pE4T/Luc_NN ,_, containing_VBG the_DT adenovirus_NN E4_NP TATA_NP box_NN ._SENT A_DT single_JJ copy_NN of_IN each_DT RRE_NN was_VBD cloned_VBN into_IN the_DT same_JJ locus_NN of_IN the_DT reporter_NN plasmid_NN ,_, pE4T/Luc_NN ,_, and_CC termed_VBD pE4T/RREs_NNS ._SENT Each_DT reporter_NN construct_NN (_( 20_CD ng_NNS )_) was_VBD transfected_VBN into_IN 293T_JJ cells_NNS with_IN 100_CD ng_NNS of_IN a_DT vector_NN ,_, pcDNA3_NN ,_, or_CC an_DT RTA_NP expression_NN plasmid_NN ,_, pcDNA3/RTA_NP ._SENT Plasmid_NP pRLSV40_NP (_( 10_CD ng_NNS )_) ,_, containing_VBG the_DT coding_VBG sequence_NN for_IN Renilla_NP luciferase_NN under_IN the_DT control_NN of_IN a_DT constitutively_RB active_JJ SV40_NP enhancer/promoter_NN ,_, was_VBD included_VBN in_IN each_DT transfection_NN and_CC served_VBN as_IN an_DT internal_JJ control_NN for_IN transfection_NN efficiency_NN ._SENT At_IN 24_CD h_NN posttransfection_NN ,_, cell_NN lysates_NNS were_VBD assayed_VBN for_IN both_DT firefly_NN and_CC Renilla_NP luciferase_NN activity_NN ._SENT Firefly_NN luciferase_NN activity_NN was_VBD normalized_VBN with_IN the_DT corresponding_JJ Renilla_NP luciferase_NN activity_NN in_IN each_DT transfection_NN ._SENT The_DT normalized_VBN levels_NNS of_IN luciferase_NN activity_NN of_IN pcDNA3-transfected_JJ cells_NNS were_VBD subtracted_VBN from_IN that_DT of_IN pcDNA3/RTA-transfected_JJ cells_NNS and_CC then_RB used_VBN as_IN levels_NNS of_IN the_DT promoter_NN activity_NN ._SENT pE4T/PAN_NN manifested_VBD the_DT strongest_JJS promoter_NN activity_NN among_IN the_DT reporter_NN constructs_NNS tested_VBD ._SENT Its_PP$ fold_NN activation_NN by_IN RTA_NP was_VBD up_RB to_TO 3,300-fold_JJ ,_, equivalent_JJ to_TO results_NNS using_VBG our_PP$ previous_JJ reporter_NN construct_NN containing_VBG a_DT minimal_JJ PAN_NP promoter_NN ,_, pLUC_NN (_( -69_CD )_) ._SENT The_DT relative_JJ promoter_NN activity_NN was_VBD calculated_VBN as_IN a_DT ratio_NN of_IN the_DT promoter_NN activity_NN of_IN reporter_NN constructs_NNS to_TO that_WDT of_IN pE4T/PAN_NN ._SENT The_DT transfections_NNS were_VBD performed_VBN at_IN a_DT suboptimal_JJ condition_NN for_IN RTA_NP to_TO avoid_VB saturating_VBG the_DT promoters_NNS ._SENT The_DT promoter_NN activities_NNS of_IN the_DT pE4T/RRE_JJ reporters_NNS in_IN the_DT presence_NN of_IN RTA_NP had_VBD an_DT order_NN similar_JJ to_TO that_DT of_IN transcription_NN rates_NNS during_IN reactivation_NN of_IN KSHV-infected_NP cells_NNS ._SENT We_PP then_RB explored_VBD the_DT possibility_NN that_IN B-cell-specific_NP or_CC viral_JJ factors_NNS are_VBP involved_VBN in_IN activating_VBG these_DT elements_NNS by_IN testing_VBG the_DT reporter_NN constructs_VBZ in_IN BJAB_NP ,_, a_DT human_JJ B-cell_NN line_NN with_IN no_DT viral_JJ infection_NN ,_, and_CC in_IN KS-1_NP ,_, a_DT PEL_NP cell_NN line_NN latently_RB infected_VBN with_IN KSHV_NP ._SENT Reporter_NN constructs_NNS (_( 50_CD ng_NNS )_) were_VBD transfected_VBN into_IN BJAB_NP cells_NNS in_IN the_DT absence_NN or_CC presence_NN of_IN pcDNA3/RTA_NP (_( 250_CD ng_NNS )_) ._SENT The_DT ratio_NN between_IN the_DT amount_NN of_IN reporter_NN constructs_NNS and_CC that_IN of_IN activator_NN transfected_VBN into_IN BJAB_NP cells_NNS was_VBD the_DT same_JJ as_RB in_IN 293T_JJ cells_NNS ._SENT pRLSV40_NP (_( 10_CD ng_NNS )_) was_VBD cotransfected_VBN to_TO serve_VB as_IN an_DT internal_JJ control_NN ._SENT KS-1_JJ cells_NNS were_VBD also_RB transfected_VBN in_IN the_DT same_JJ condition_NN as_IN BJAB_NP cells_NNS ._SENT Promoter_NN activity_NN of_IN pKpsn_NN RRE_NN in_IN comparison_NN of_IN that_DT of_IN pPAN_NP RRE_NP was_VBD less_RBR strong_JJ in_IN BJAB_NP cells_NNS than_IN in_IN 293T_JJ or_CC KS-1_JJ cells_NNS ._SENT Differences_NNS among_IN promoter_NN activities_NNS of_IN other_JJ RREs_NP were_VBD less_RBR prominent_JJ in_IN KS-1_NP cells_NNS than_IN in_IN 293T_JJ cells_NNS ,_, suggesting_VBG that_IN there_EX might_MD be_VB other_JJ factors_NNS involved_VBN in_IN activation_NN of_IN RREs_NP from_IN the_DT Kpsn_NP ,_, ORF57_JJ ,_, and_CC vIL-6_JJ promoters_NNS ._SENT However_RB ,_, the_DT relative_JJ promoter_NN strengths_NNS of_IN pE4T/RREs_NNS in_IN BJAB_NP and_CC KS-1_NP cells_NNS were_VBD similar_JJ to_TO those_DT in_IN 293T_JJ cells_NNS ,_, indicating_VBG that_IN RTA_NP is_VBZ the_DT main_JJ contributing_VBG factor_NN to_TO the_DT promoter_NN activity_NN ._SENT We_PP compared_VBD relative_JJ promoter_NN strengths_NNS in_IN a_DT different_JJ promoter_NN context_NN by_IN cloning_VBG a_DT copy_NN of_IN each_DT RRE_NN into_IN another_DT heterologous_JJ promoter_NN ,_, such_JJ as_IN SV40_NP promoter_NN ._SENT Results_NNS from_IN transient_JJ transfections_NNS in_IN 293_CD cells_NNS were_VBD consistent_JJ with_IN previous_JJ results_NNS showing_VBG RRE_JJ promoter_NN strengths_NNS ,_, although_IN levels_NNS of_IN the_DT promoter_NN activity_NN were_VBD lower_JJR in_IN 293_CD cells_NNS than_IN in_IN 293T_JJ cells_NNS ,_, mainly_RB due_JJ to_TO high_JJ basal_JJ activity_NN of_IN the_DT reporters_NNS ._SENT After_IN all_DT ,_, these_DT results_NNS suggest_VBP that_IN the_DT RREs_NP may_MD be_VB a_DT primary_JJ contributor_NN in_IN regulating_VBG gene_NN expression_NN ,_, regardless_RB of_IN B-cell-specific_NP or_CC viral_JJ factors_NNS and_CC types_NNS of_IN heterologous_JJ promoters_NNS ._SENT RTA_NP binds_VBZ viral_JJ RREs_NNS with_IN various_JJ affinities_NNS ._SENT |_SYM Although_IN each_DT of_IN four_CD RREs_NP has_VBZ been_VBN shown_VBN to_TO confer_VB RTA_NP binding_VBG using_VBG different_JJ protein_NN expression_NN systems_NNS by_IN different_JJ groups_NNS ,_, a_DT recent_JJ study_NN showing_VBG that_IN RTA_NP might_MD be_VB recruited_VBN by_IN a_DT cellular_JJ transcriptional_JJ factor_NN ,_, RBP-Jkappa_NP ,_, to_TO the_DT ORF57_JJ promoter_NN ,_, suggested_VBD a_DT complicated_JJ mode_NN of_IN gene_NN regulation_NN by_IN RTA_NP ._SENT In_IN addition_NN ,_, results_NNS from_IN the_DT mutagenesis_NN study_NN of_IN pORF57_JJ RRE_NN indicated_VBD that_IN there_EX might_MD be_VB a_DT sequence_NN requirement_NN for_IN this_DT promoter_NN activation_NN by_IN RTA_NP ,_, other_JJ than_IN a_DT simple_JJ RBP-Jkappa_NP binding_JJ site_NN ,_, thus_RB serving_VBG as_IN a_DT composite_JJ si_NP 